TuHURA Biosciences (HURA) Other Non-Current Liabilities (2011 - 2025)
TuHURA Biosciences' (HURA) quarterly Other Non-Current Liabilities came in at $84985.0 in Q3 2025, up 102.78% quarter-over-quarter from -$3.1 million in Q1 2025.
TuHURA Biosciences (HURA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
TuHURA Biosciences' Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $84985.0 for Q3 2025.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $84985.0 in Q3 2025; TTM through Sep 2025 was $84985.0, a N/A change from a year earlier, with the FY2023 full-year figure at $137000.0, changed N/A from the prior year.
- Other Non-Current Liabilities improved to $84985.0 in Q3 2025 per HURA's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $137000.0 in Q4 2023 and bottomed at -$3.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 84,985.00 |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2023 | 137,000.00 |
| Jun 30, 2020 | 8.52 Mn |
| Mar 31, 2020 | 8.38 Mn |
| Dec 31, 2019 | 8.31 Mn |
| Sep 30, 2019 | 8.28 Mn |
| Mar 31, 2019 | 265.00 |
| Dec 31, 2018 | 76.00 |
| Sep 30, 2018 | 1,337.00 |
| Jun 30, 2018 | 1,117.00 |
| Mar 31, 2018 | 3,389.00 |
| Dec 31, 2017 | 5,549.00 |
| Sep 30, 2017 | 4,660.00 |
| Jun 30, 2017 | 4.57 Mn |
| Mar 31, 2017 | 91,545.00 |
| Dec 31, 2016 | 171,211.00 |
| Sep 30, 2016 | 590,345.00 |
| Jun 30, 2016 | 693,700.00 |
| Mar 31, 2016 | 1.19 Mn |